Home
Conditions
Cytokine Release Syndrome

Clinical trial condition

Cytokine Release Syndrome

Explore clinical trials studying Cytokine Release Syndrome. Study availability and eligibility vary by location and protocol.

27 public trials 5 recruiting studies

Refine in advanced search Browse all conditions

Cytokine Release Syndrome trial results

Recruiting

Study of CTO1681 for the Prevention and Treatment of CRS in Patients Receiving CAR T-Cell Therapy

NCT05905328

Conditions: Cytokine Release Syndrome, Inflammation, Pathologic Processes, +3 more
Locations: University of California, Irvine - Chao Family Comprehensive Cancer Center Orange, California, United States

Georgia Cancer Center at Augusta University Augusta, Georgia, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Duke Cancer Institute Durham, North Carolina, United States

View Trial Details

Recruiting

Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed or Refractory Myeloma

NCT07657312

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Cytokine Release Syndrome, +20 more
Locations: Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States

View Trial Details

Recruiting

Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab

NCT06447376

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
Locations: Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Recruiting

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy

NCT07390071

Conditions: Cytokine Release Syndrome, Hemic and Lymphatic Diseases, Immune Effector Cell Associated Neurotoxicity Syndrome, +14 more
Locations: Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States

View Trial Details

Recruiting

Adjunctive Methylene Blue for Immunotherapy-related CRS and ICANS: Phase I Study

NCT07169487

Conditions: Cytokine Release Syndrome, ICANS, Inflammation, +4 more
Locations: Institute of Hematology & Blood Diseases Hospital Tianjin, Tianjin Municipality, China

View Trial Details

Enrolling by invitation

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

NCT07499128

Conditions: Antibodies Bispecific, Blood Protein Disorders, Body Temperature, +36 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Completed

Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy

NCT04975555

Conditions: Acute Lymphoblastic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +26 more
Locations: University of Alabama at Birmingham Birmingham, Alabama, United States

View Trial Details

Completed

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

NCT04150913

Conditions: Chemically-Induced Disorders, Cytokine Release Syndrome, Hemic and Lymphatic Diseases, +20 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital

NCT04979884

Conditions: COVID-19, COVID-19 Acute Respiratory Distress Syndrome, Coronaviridae Infections, +21 more
Locations: Alexandria university Alexandria, Egypt

View Trial Details

Completed

A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy

NCT04071366

Conditions: Cytokine Release Syndrome, Inflammation, Pathologic Processes, +3 more
Locations: University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States

Moffitt Cancer Center Tampa, Florida, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Washington University School of Medicine St Louis, Missouri, United States

View Trial Details

Cytokine Release Syndrome

Cytokine Release Syndrome trial results

Related conditions